Develops in-vitro diagnostic products for medical testing.
Dec 2025Revenue $8.65M/yrExpenses $2.88M/yr
No trend
Figures by year
Is Anbio Biotechnology profitable?
Yes. In the 12 months to Dec 2025, revenue was $8.65M and expenses $2.88M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $8.65M | $2.88M | $5.77M |
| Dec 2024 | $8.19M | $6.19M | $2.00M |
| Dec 2023 | $6.71M | $4.75M | $1.96M |
| Dec 2022 | $23.5M | $13.3M | $10.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.